PL2974733T3 - Połączenie wyciągu z korzenia kozłka lekarskiego i olejku lawendowego do zastosowania w leczeniu zaburzeń snu - Google Patents

Połączenie wyciągu z korzenia kozłka lekarskiego i olejku lawendowego do zastosowania w leczeniu zaburzeń snu

Info

Publication number
PL2974733T3
PL2974733T3 PL14176927T PL14176927T PL2974733T3 PL 2974733 T3 PL2974733 T3 PL 2974733T3 PL 14176927 T PL14176927 T PL 14176927T PL 14176927 T PL14176927 T PL 14176927T PL 2974733 T3 PL2974733 T3 PL 2974733T3
Authority
PL
Poland
Prior art keywords
treatment
combination
root extract
sleep disorders
lavender oil
Prior art date
Application number
PL14176927T
Other languages
English (en)
Inventor
Wilfried Dimpfel
Michael Nöldner
Original Assignee
Dr. Willmar Schwabe Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr. Willmar Schwabe Gmbh & Co. Kg filed Critical Dr. Willmar Schwabe Gmbh & Co. Kg
Publication of PL2974733T3 publication Critical patent/PL2974733T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/84—Valerianaceae (Valerian family), e.g. valerian
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Psychology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL14176927T 2014-07-14 2014-07-14 Połączenie wyciągu z korzenia kozłka lekarskiego i olejku lawendowego do zastosowania w leczeniu zaburzeń snu PL2974733T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14176927.3A EP2974733B1 (de) 2014-07-14 2014-07-14 Kombination von Baldrianwurzelextrakt und Lavendelöl zur Verwendung zur Behandlung von Schlafstörungen

Publications (1)

Publication Number Publication Date
PL2974733T3 true PL2974733T3 (pl) 2017-09-29

Family

ID=51167804

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14176927T PL2974733T3 (pl) 2014-07-14 2014-07-14 Połączenie wyciągu z korzenia kozłka lekarskiego i olejku lawendowego do zastosowania w leczeniu zaburzeń snu

Country Status (16)

Country Link
US (1) US10357530B2 (pl)
EP (1) EP2974733B1 (pl)
JP (1) JP6474114B2 (pl)
KR (1) KR102231129B1 (pl)
CN (1) CN106573029B (pl)
AU (1) AU2015291363B2 (pl)
CA (1) CA2953190C (pl)
ES (1) ES2597784T3 (pl)
HU (1) HUE031669T2 (pl)
MX (1) MX2017000472A (pl)
MY (1) MY177827A (pl)
PL (1) PL2974733T3 (pl)
PT (1) PT2974733T (pl)
RU (1) RU2672876C2 (pl)
TW (1) TWI654987B (pl)
WO (1) WO2016008650A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7576905B2 (ja) 2016-05-06 2024-11-01 ソシエテ・デ・プロデュイ・ネスレ・エス・アー バレリアン組成物及び関連方法
CN108042658A (zh) * 2017-11-17 2018-05-18 贵州苗药生物技术有限公司 一种缬草苗药睡眠精油组合物及其制备方法和应用
JP6961481B2 (ja) * 2017-12-26 2021-11-05 株式会社ファンケル 脳血流改善用組成物
CN111388572A (zh) * 2020-04-13 2020-07-10 北京中医药大学 一种复方精油及其制备方法、制剂和应用
JP2025501818A (ja) * 2022-01-18 2025-01-24 オムニアクティブ ヘルス テクノロジーズ リミテッド 睡眠管理のためのバレリアン組成物
KR102885894B1 (ko) * 2022-12-30 2025-11-19 농업회사법인우포의아침 주식회사 천연 추출물을 이용한 수면장애 개선 식품 제조방법
CN118600573B (zh) * 2024-04-10 2025-02-07 和也健康科技有限公司 一种薰衣草、缬草改性植物基纤维及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2106873C1 (ru) * 1994-03-16 1998-03-20 Николай Николаевич Бобров-Егоров Бальзамическое биологически активное средство - фитаон-4 и способ его получения
JPH1025246A (ja) * 1996-07-11 1998-01-27 Kobayashi Pharmaceut Co Ltd 催眠剤、催眠性飲食物及び催眠性餌料
RU2215536C2 (ru) * 1999-07-15 2003-11-10 Сергей Иванович Гулый Биологически активная пищевая добавка лечебно-профилактического действия, обладающая седативными свойствами, способ ее получения
US6869622B2 (en) * 1999-07-21 2005-03-22 Ancile Pharmaceuticals, Inc. Composition for improving sleep quality and efficiency, and methods of preparing and using the composition
DE102004048716A1 (de) * 2004-10-06 2006-04-20 Dr. Willmar Schwabe Gmbh & Co. Kg Verwendung von Lavendelöl zur Prophylaxe und Behandlung von Neurasthenie, Somatisierungsstörungen und von anderen stress-assoziierten Erkrankungen
WO2007095716A1 (en) * 2006-02-23 2007-08-30 Iomedix Sleep International Srl Compositions and methods for the induction and maintenance of quality sleep
US20090061029A1 (en) * 2007-08-28 2009-03-05 Kaira Rouda Nighttime water
EP2373286A4 (en) * 2008-12-03 2015-03-18 Elc Man Llc COMPOSITIONS AND METHODS FOR PROMOTING A RELAXATION STATUS
EP2533790A2 (de) * 2010-02-09 2012-12-19 Reiner Rittinghausen Zusammmensetzung zur behandlung und prophylaxe von nervösen störungen und schlafstörungen
KR20130070608A (ko) * 2010-05-10 2013-06-27 세게티스, 인코포레이티드. 미립자 고체에 대한 분산제 및 슬립제로서의 알킬 케탈 에스터 및 그의 제조방법, 및 용도
KR20120122109A (ko) * 2011-04-28 2012-11-07 애경산업(주) 허브 추출물을 함유하는 탈모 방지 및 양모 촉진용 모발 또는 두피 화장료 조성물
US20130004599A1 (en) * 2011-06-30 2013-01-03 Masada Health & Beauty Corporation Formulation for transdermal delivery to promote sleep
KR101296920B1 (ko) * 2013-01-21 2013-08-14 강영숙 숙면을 위한 마사지 오일
CN103142910B (zh) * 2013-03-08 2014-07-09 张风华 安神脐贴
US9375463B2 (en) * 2013-09-10 2016-06-28 Creative Medical Health, Inc. Compositions and methods for improving sleep using a nutraceutical formulation
CN103750535B (zh) * 2014-01-22 2015-12-02 红云红河烟草(集团)有限责任公司 一种加热非燃烧型卷烟烟块的制备方法
US20150283072A1 (en) * 2014-03-20 2015-10-08 Santé, Llc Pre-operative beverages

Also Published As

Publication number Publication date
US20170296612A1 (en) 2017-10-19
MY177827A (en) 2020-09-23
US10357530B2 (en) 2019-07-23
KR102231129B1 (ko) 2021-03-24
RU2672876C2 (ru) 2018-11-20
JP6474114B2 (ja) 2019-02-27
MX2017000472A (es) 2017-04-27
HUE031669T2 (en) 2017-07-28
RU2017101445A (ru) 2018-08-14
WO2016008650A1 (de) 2016-01-21
CA2953190A1 (en) 2016-01-21
TWI654987B (zh) 2019-04-01
TW201613628A (en) 2016-04-16
CN106573029A (zh) 2017-04-19
AU2015291363A1 (en) 2017-01-12
ES2597784T3 (es) 2017-01-23
CA2953190C (en) 2022-05-24
AU2015291363B2 (en) 2020-04-02
RU2017101445A3 (pl) 2018-08-14
JP2017521446A (ja) 2017-08-03
EP2974733B1 (de) 2016-09-07
EP2974733A1 (de) 2016-01-20
PT2974733T (pt) 2016-10-24
CN106573029B (zh) 2021-05-11
KR20170029604A (ko) 2017-03-15

Similar Documents

Publication Publication Date Title
GB2542155B (en) Use of cannabidiol in the treatment of mental disorders
IL259751B (en) Polycyclic compounds and their use in the treatment of immune disorders
GB2548873B (en) Use of Cannabidiol in the Treatment of SturgeWeber Syndrome
GB201411496D0 (en) Use of 7-Oh-Cannabidiol (7-Oh-CBD) and/or 7-Oh-Cannabidvarin (7-Oh-CBDV) in the treatment of epilepsy
IL252943A0 (en) Sunitinib formulations and methods of using them for the treatment of eye diseases
ZA201507155B (en) Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders
HUE061761T2 (hu) Tetrahidropiranil-amino-pirrolopirimidinon felhasználásra BTK-által közvetített zavarok kezelésében
SI3004110T1 (sl) Pirazolopirolidinski derivati in njihova uporaba pri zdravljenju bolezni
ZA201901055B (en) Treatment and prevention of sleep disorders
HUE036084T2 (hu) Buprenorfin dimer és alkalmazása gasztrointesztinális rendellenességek kezelésénél
SMT202500469T1 (it) Combinazione farmaceutica comprendente ponesimod e suo utilizzo nel trattamento della sclerosi multipla
PL3215157T3 (pl) Apilimod do stosowania w leczeniu czerniaka
IL250484A0 (en) Heterovesicular compounds and their use in the treatment of tuberculosis
MY177827A (en) Combination of valerian root extract and lavender oil for use in the treatment of sleep disorders
HUE039750T2 (hu) Hidroxi-buspiron mozgászavarok kezelésére
IL246855A0 (en) Materials for use in the treatment of retinitis
GB201423272D0 (en) The combination for anti-wrinkle and soothing the skin
IL251736B (en) Methods and compositions for the treatment of radiation-related disorders
PT3234597T (pt) Proteínas da via de sinalização wnt e suas utilizações no diagnóstico e tratamento de distúrbios de hipopigmentação
PL3212280T3 (pl) Dopasowanie szumu usznego u pacjentów z implantem ślimakowym (CI) i implantem słuchowym pnia mózgu (ABI)
GB201423270D0 (en) The combination for soothing and repair of the skin
IL251840A0 (en) Use of femiroplast in the treatment of severe asthma
IL243192A0 (en) Therapeutic agents for use in the prophylaxis and/or treatment of hyperkinetic movement disorders
PL3166660T3 (pl) Substancje i sposoby do zastosowania w profilaktyce i/lub leczeniu choroby Huntingtona
IL251407A0 (en) A multivalent compound for the treatment and prevention of brain damage